Mitoxantrone plus gemcitabine in pretreated patients with advanced breast cancer.

被引：0
|
作者：
Onyenadum, A [1 ]
Kosmidis, P [1 ]
Aravantinos, G [1 ]
Bafaloukos, D [1 ]
Gogas, H [1 ]
Bacoyiannis, C [1 ]
Razis, E [1 ]
Markopoulos, C [1 ]
Makatsoris, T [1 ]
Kalofonos, HP [1 ]
机构：
[1] Hellen Cooperat Oncol Grp, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
829
引用
下载
收藏
页码：83S / 83S
页数：1
相关论文
共 50 条
  • [1] Mitoxantrone plus vinorelbine in pretreated patients with advanced breast cancer.
    Onyenadum, A
    Gogas, H
    Markopoulos, C
    Bafaloukos, D
    Aravantinos, G
    Koutras, A
    Makatsoris, T
    Koukouras, D
    Pavlidis, N
    Kalofonos, HP
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 93S - 93S
  • [2] Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancer
    Onyenadum, A.
    Gogas, H.
    Kosmidis, P.
    Aravantinos, G.
    Bafaloukos, D.
    Bacoyiannis, H.
    Markopoulos, C.
    Koutras, A.
    Tzorakoelefterakis, E.
    Makatsoris, T.
    Fountzilas, G.
    Kalofonos, H. P.
    JOURNAL OF CHEMOTHERAPY, 2006, 18 (02) : 192 - 198
  • [3] Gemcitabine plus cisplatin in pretreated metastatic breast cancer.
    Moura, G. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancer.
    Gennatas, C
    Mouratidou, D
    Tsavaris, N
    Andreadis, C
    Michalaki, V
    Psychogios, J
    Poulakaki, N
    Gennatas, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 63S - 63S
  • [5] Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer
    Onyenadum, A.
    Gogas, H.
    Markopoulos, C.
    Bafaloukos, D.
    Aravantinos, G.
    Mantzourani, M.
    Koutras, A.
    Tzorakoelefterakis, E.
    Xiros, N.
    Makatsoris, T.
    Fountzilas, G.
    Kalofonos, H. P.
    JOURNAL OF CHEMOTHERAPY, 2007, 19 (05) : 582 - 589
  • [6] Gemcitabine plus cisplatin patients with heavily pretreated advanced breast cancer with brain metastases.
    Gorbunova, V. A.
    Bychkov, M. B.
    Naskhletashvili, D. R.
    Chmutin, G. E.
    Karahan, V. B.
    Aloshin, V. A.
    Moskvina, E. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Phase III study of vinflunine plus gemcitabine versus paclitaxel plus gemcitabine in the first-line treatment of anthracycline pretreated advanced breast cancer.
    Llombart, Antonio
    Espie, Marc
    Ranade, Anantbhushan
    Trukhin, Dmytro
    Hegg, Roberto
    Del Giglio, Auro
    Paridaens, Robert
    Staroslawska, Elzbieta
    Veyret, Corinne
    Sakaeva, Dina
    Gomez, Henry Leonidas
    Lokanatha, Dasappa
    Lerzo, Guillermo Luis
    Shewalkar, Balaji Keshavrao
    Talbot, Denis Charles
    Santoro, Armando
    Roche, Henri Hubert
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Phase I/II study of gemcitabine plus mitoxantrone in advanced breast cancer (ABC)
    Lorusso, V
    Catino, A
    Mancarella, S
    D'Amico, C
    Latrorre, A
    Guida, M
    Sambiasi, D
    De Lena, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S317 - S317
  • [9] Clinical experience with fulvestrant in pretreated patients with advanced breast cancer.
    Menjon Beltran, S.
    Garcia Garcia, J., Sr.
    Gonzalez Flores, E.
    Conde Herrero, V.
    Gonzalez Jimenez, E., Sr.
    Gutierrez Lomas, V., Sr.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] MITOXANTRONE, FLUOROURACIL PLUS L-LEUCOVORIN, AND VINORELBINE IN PRETREATED ADVANCED BREAST-CANCER
    COLLEONI, M
    NELLI, P
    GAION, F
    SGARBOSSA, G
    MANENTE, P
    ONCOLOGY, 1995, 52 (06) : 435 - 438
12345